Effect of Electroacupuncture on P6 Acupoint on Hypertensive Patients.
EEP6
1 other identifier
interventional
150
1 country
1
Brief Summary
This is a randomized controlled clinical trial with three parallel arms. This trial aims to evaluate the effectiveness of electroacupuncture on P6 acupoint for patients with hypertension,with respect to decreasing their blood pressure, safety of acupuncture ,and improving their quality of life as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Sep 2020
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2020
CompletedFirst Posted
Study publicly available on registry
August 14, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedAugust 14, 2020
August 1, 2020
5 months
August 11, 2020
August 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reduction of blood pressure.
It is expected that both blood pressure and heart rate will be reduced during the electroacupuncture of P6 acupoint.
up to 6 months
Reduction of Heart Rate
Heart Rate is also expected to be reduced with the stimulation of p6 acupoint.
up to 6 months
Study Arms (3)
Unilateral electroacupuncture of p6 acupoint
EXPERIMENTALBilateral electroacupuncture of p6 acupoint
EXPERIMENTALSham acupuncture of p6 acupoint
SHAM COMPARATORInterventions
In each session, acupuncture are applied unilaterally or bilaterally on P6 acupoint. Each acupuncture needle will be stimulated by transcutaneous electric device.
Eligibility Criteria
You may qualify if:
- Patients above 18 years old
- Have not recently had any changes in anti-hypertensive medications
- Have not recently been discharged from hospital/are stable
- Is not having any acute infection.
You may not qualify if:
- Trypanophobia
- Below 18 years of age
- Is currently having an acute infection
- Is unstable or have been discharged recently from hospital
- Changes made to anti-hypertensive medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ong Fujian Chinese Physician Hall
Singapore, 427513, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lin Ho Wong, MB BCH BAO
Ong Fujian Chinese Physician Hall
- PRINCIPAL INVESTIGATOR
Pang Ong Wong, PhD
Ong Fujian Chinese Physician Hall
- STUDY CHAIR
Eng Soon Ong, Bachelor of TCM
Ong Fujian Chinese Physician Hall
- STUDY CHAIR
Choo Keok Lim, PhD
Ong Fujian Chinese Physician Hall
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 11, 2020
First Posted
August 14, 2020
Study Start
September 1, 2020
Primary Completion
February 1, 2021
Study Completion
April 30, 2021
Last Updated
August 14, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share